id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-E-0584-0005,FDA,FDA-2009-E-0584,Determination of Regulatory Review Period for Purposes of Patent Extension: Besivance,Notice,N-Notice,2010-12-06T05:00:00Z,2010,12,2010-12-06T05:00:00Z,,2010-12-08T16:21:28Z,2010-30510,0,0,0900006480baff29
FDA-2009-E-0584-0004,FDA,FDA-2009-E-0584,FDA/CDER to U.S. Patent Trademark Office - Letter,Other,LET-Letter,2010-10-28T04:00:00Z,2010,10,2010-10-28T04:00:00Z,,2010-10-28T19:40:00Z,,0,0,0900006480b79edf
FDA-2009-E-0584-0003,FDA,FDA-2009-E-0584,FDA/CDER to US Patent and Trademark Office - Letter,Other,LET-Letter,2010-05-11T04:00:00Z,2010,5,2010-05-11T04:00:00Z,,2013-07-27T23:18:42Z,,0,0,0900006480aeb5cc